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The porosity of liver sinusoidal endothelial cells (LSEC) ensures bidirectional passive
transport of lipoproteins, drugs and solutes between the liver capillaries and the
liver parenchyma. This porosity is realized via fenestrations – transcellular pores with
diameters in the range of 50–300 nm – typically grouped together in sieve plates.
Aging and several liver disorders severely reduce LSEC porosity, decreasing their
filtration properties. Over the years, a variety of drugs, stimulants, and toxins have
been investigated in the context of altered diameter or frequency of fenestrations. In
fact, any change in the porosity, connected with the change in number and/or size of
fenestrations is reflected in the overall liver-vascular system crosstalk. Recently, several
commonly used medicines have been proposed to have a beneficial effect on LSEC
re-fenestration in aging. These findings may be important for the aging populations
of the world. In this review we collate the literature on medicines, recreational drugs,
hormones and laboratory tools (including toxins) where the effect LSEC morphology
was quantitatively analyzed. Moreover, different experimental models of liver pathology
are discussed in the context of fenestrations. The second part of this review covers the
cellular mechanisms of action to enable physicians and researchers to predict the effect
of newly developed drugs on LSEC porosity. To achieve this, we discuss four existing
hypotheses of regulation of fenestrations. Finally, we provide a summary of the cellular
mechanisms which are demonstrated to tune the porosity of LSEC.
Keywords: fenestration, fenestra, nanopores, LSEC, liver sinusoidal endothelial cells, porosity, liver disease, drug
response
INTRODUCTION
Within the human body, the main blood-organ barrier is made up of a single layer of thin
endothelial cells. In the liver, the microcirculation has a unique morphology that facilitates bi-
directional exchange of substrates between hepatocytes and blood in the liver sinusoids (Cogger
and Le Couteur, 2009; Fraser et al., 2012). Liver sinusoidal endothelial cells (LSEC) are very thin
and perforated with transcellular pores (50–300 nm in diameter) that are also termed as fenestrae
or fenestrations (Figure 1). These structures were first correctly identified as such with transmission
electron microscopy (TEM) by Yamagishi (1959) and described in detail by Wisse (1970). Between
2 and 20% of the LSEC surface is covered by fenestrations which are either scattered individually
across the surface or clustered into groups called sieve plates. As there are no diaphragms or
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underlying basement membrane, fenestrations make LSEC a
highly efficient ultrafiltration system. LSEC thus retain blood
cells inside the vessel lumen, whereas small molecules, such as
drugs, proteins, lipoproteins, and small viruses can pass this
endothelial barrier via fenestrations to reach the surrounding
hepatocytes, and vice versa (Fraser et al., 1995a). Fenestrations
are therefore a vital structure in liver physiology, providing the
primary communication conduit between the liver and the rest of
the body, via the circulation. LSEC fenestrations, and the effects
of various agents upon them, have been studied extensively with
electron microscopy. During the last decade new techniques have
been developed and became available to investigate fenestrations
in cultured LSEC. Super-resolution optical microscopy provided
first detailed information about the composition of fenestration
(Cogger et al., 2010, 2013; Mönkemöller et al., 2015; Zapotoczny
et al., 2019a) while atomic force microscopy (AFM) provided
first information about the dynamics of fenestrations in vitro
(Zapotoczny et al., 2019b, 2020). Such tools will accelerate the
development of therapies that can reverse the loss of fenestrations
seen in aging and liver fibrosis (DeLeve, 2015; Hunt et al., 2019).
Fenestration loss during aging manifests as changes in the
liver microcirculation, in particular within LSEC, which is a
likely cause of dyslipidemia (Le Couteur et al., 2002) and
insulin resistance in old age (Mohamad et al., 2016). At the
morphological level, LSEC in old age have markedly reduced
porosity (percent of the cell surface area covered in fenestrations)
by about 50% – in other words, old LSEC become “defenestrated”
(Figure 2). This defenestration results in hampered bi-directional
traffic of substrates between the blood and the hepatocytes.
Biomolecules such as lipoproteins, or hormones, or drugs (such
as statins or insulin) pass less easily through aged LSEC to
reach the hepatocytes to be processed and/or exert their effects.
For example, older rats showed a significant reduction in
the hepatic volume of insulin distribution (Mohamad et al.,
2016), showing that fenestrations facilitate insulin transfer to
hepatocytes. Another example is the transfer of lipoproteins
across LSEC, which was almost totally abolished in livers
from old animals, providing a novel mechanism for age-related
dyslipidemia and postprandial hyperlipidemia (Hilmer et al.,
2005) and is now accepted as a significant factor in age-related
hyperlipidemia (Liu et al., 2015). The same applies in the
reverse direction across LSEC – biomolecules produced by the
hepatocytes need to pass through fenestrations for release into
the plasma, and defenestration hinders this process. Age-related
LSEC defenestration is also accompanied by altered expression
of many vascular proteins including von Willebrand factor,
ICAM-1, laminin, caveolin-1 and various collagens (Le Couteur
et al., 2008). However, these changes occur without any age-
related pathology of hepatocytes or activation of stellate cells
(Warren et al., 2011). The sum of all these processes results
in a state whereby liver sinusoidal vessels become more like
continuous capillaries, but without the other manifestations
seen in diseased livers during “capillarization.” Age-related
defenestration is therefore also termed “pseudocapillarization.”
Cellular senescence is one hallmark of aging (Robbins et al.,
2021), and (Grosse et al., 2020) proposed that LSEC become
senescent at 10–12 months of age in mice, as evidenced by the
increased expression of the senescence marker p16. Senolytic
drugs (which selectively kill senescent cells) have been proposed
as a potential therapy to alleviate the effects of senescent cell
mediated aging and disease (Robbins et al., 2021). However,
p16high LSEC are essential for mouse healthspan, as ablation of
these cells results in disruption of the hepatic sinusoid and liver
fibrosis (Grosse et al., 2020).
Defenestration of LSEC also occurs during chronic liver
disease, liver fibrosis and consequently cirrhosis, which are an
increasing worldwide problem, and are becoming a major cause
of morbidity and death (Asrani et al., 2019). Currently, there is no
therapy that can alleviate fibrosis progression or reverse fibrosis
(Higashi et al., 2017). Fibrosis is characterized by excessive
extracellular matrix production from activated stellate cells. In
addition to LSEC defenestration, during chronic liver disease, a
basement membrane develops in the Space of Disse, leading to
the process of capillarization, and thereby further reducing the
free passage of substrates to and from the hepatocytes (Poisson
et al., 2017). Defenestration of LSEC occurs earlier than the
formation of fibrous septa in liver diseases such as alcoholic
liver injury and non-alcoholic fatty liver disease (Horn et al.,
1987) which could indicate that LSEC can play an important role
during the early stages of fibrosis. Restoration of differentiation
to LSEC led to quiescence of hepatic stellate cells and regression
of fibrosis in thioacetamide challenged rats (Xie et al., 2012b)
potentially suggesting that therapies that revert LSEC from a
diseased/defenestrated state to a normal state may also be of
benefit for treatment of liver fibrosis (DeLeve, 2015).
As mentioned above, defenestration of the liver sinusoidal
endothelium impairs the hepatic clearance of pharmacological
agents (Mitchell et al., 2011). As for lipoproteins and insulin,
fenestrations are conduits for pharmaceuticals, from the plasma
to the hepatocytes. Reduction in LSEC porosity thus reduces
the passage of drugs to the cells where they are processed
and metabolized. This can result in elevated and potentially
toxic concentrations of drugs in the elderly (and patients with
liver disease), when administering drug doses appropriate for
healthy young people. In addition, polypharmacy is becoming
a major issue in the aging population, with over 42% of people
over 65 years of age were reported being administrated five or
more different medications per day (Midão et al., 2018). The
majority of these medications need to cross the liver sinusoidal
endothelium to be detoxified, and it is possible that some of
the polypharmacy “cocktails” are detrimental for LSEC porosity.
Another serious consequence of reduced porosity is that statins
are less able to reach the hepatocytes and inhibit cholesterol
production. Increased statin doses are then required to achieve
therapeutic effects, sometimes resulting in side effects such as
muscle pain and rhabdomyolysis, resulting in medication non-
compliance in patients.
Given the vital role of LSEC fenestrations (and the bi-
directional flow of substrates through them) in physiology and
homeostasis, a better understanding of how these structures are
regulated will enable us to design novel therapeutic approaches
targeting biological changes of aging and liver diseases.
It needs to be highlighted, however, that many reports in the
literature “suffer” from developing experimental methodologies.
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FIGURE 1 | SEM image of hepatic sinusoids of a C57BL6 mouse, approximately 4 months old. Liver Sinusoidal Endothelial Cells (LSECs) are covered in multiple
fenestrations (arrows) arranged into sieve plates (SP, dotted line circles) distributed over the whole sinusoid. SD, space of Disse; HC, hepatocytes. (Courtesy of
Karen K. Sørensen, UiT, Tromsø, Norway).
FIGURE 2 | Sinusoidal lumen in young and old liver. With age, the fenestrated morphology of the sinusoids is lost in the process of “pseudocapillarization.”
Additionally, the endothelium thickens and collagen deposits can be found within the space of Disse. The result is the inhibition of transfer between the blood and
hepatocytes. (Courtesy of Eike Struck, UiT, Tromsø, Norway and David Le Couteur, ANZAC Research Institute, Sydney, Australia).
Errors during liver perfusion, cell isolation methodologies and
sample preparations may lead to altered cell phenotypes. Also, it
should be noted that studies from pre-super-resolution era where
light microscopy was the only technique used for quantification
of fenestrations may be imprecise. As reported, fenestrations in
LSEC are in the range of 50–300 nm, gathered in sieve plates of
several to tens of pores, with limited number of gaps (DeLeve
and Maretti-Mira, 2017). These can be visualized only using
non-diffraction limited methods such as electron microscopy,
optical nanoscopy, or atomic force microscopy. The distribution
of fenestration diameter in this range was presented for both
LSEC in tissue (in vivo) and for isolated cells (in vitro). In vivo
data are limited to fixed and dried material, while data for isolated
LSEC covers fixed and dried, wet-fixed, and live cells. Recently, we
summarized that the differences in mean fenestration diameter
for fixed and dried, wet-fixed and live LSECs in vitro can be up
to 30% (Supplementary Table 1 in Zapotoczny et al., 2019b). The
differences between in vivo and in vitro data can be even larger
ibid., (Wisse et al., 2010). The comparison between the groups
in a single report provides information about the alterations as
the same microscopy method is applied. The methodological
details enabling avoiding errors in imaging and data analysis
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were described: SEM (Wisse et al., 2010; Cogger et al., 2015;
Szafranska et al., 2021), AFM (Zapotoczny et al., 2017a, 2020;
Szafranska et al., 2021), SIM (Kong et al., 2021; Szafranska
et al., 2021). Moreover, the comparative measurements using
different microscopies were reported in the past showing good
correlation between the methods. However, the comparative
analysis of newly developed techniques applied recently for
LSECs, such as SIM, STED, and AFM, is lacking. Each method
has its advantages and limitations. To enable easy tracking of the
model (in vivo/in vitro and microscopy technique) we provide the
relevant information in the presented tables.
The purpose of this review is to: (i) provide a medical and
cell biology “tool-kit,” for researchers and clinicians to design
potential LSEC refenestration strategies and (ii) summarize the
existing knowledge around fenestration biology which can help
to find new ways to reveal how fenestrations actually work.
The first part of this review fucuses on the reported influence
of drugs on LSEC fenestration number and porosity, while
the second part gives a deeper knowledge about fenestration
biology and mechanisms behind structure, formation and
maintenance of fenestration. This review does not cover a
number of other aspects of LSEC biology, but these can be
found in in the following excellent reviews about LSEC in:
diseases (Gracia-Sancho et al., 2021; Wang and Peng, 2021),
hepatic fibrosis (DeLeve, 2015), mechanotransduction (Shu et al.,
2021), inflammation and cancer (Wilkinson et al., 2020; Yang
and Zhang, 2021), receptor expression (Pandey et al., 2020),
immunological functions (Shetty et al., 2018), aging (Hunt et al.,
2019), scavenging (Sørensen et al., 2012), and overall biology of
LSECs (Sørensen et al., 2015).
LSEC AND DRUG INTERACTIONS
Recreational and Medicinal Drugs, and
Their Effects on LSEC Porosity
The human race already uses an extensive array of drugs
for medical and recreational purposes. The majority of these
compounds are safe, or at least relatively safe for normal human
consumption if used appropriately. Reported negative side-effects
of these drugs are typically well-documented at the systemic
or organ level, but little is known about their direct effects on
LSEC fenestration status. Additionally, some drugs with other
intended targets may actually have positive side effects on LSEC
fenestration, leading to increased LSEC porosity and improving
bi-directional exchange of solutes between hepatocytes and
plasma. This concept was first tested by Hunt et al. (2019,
2020) who found that a number of drugs for intended use for
the treatment of high blood pressure, erectile dysfunction and
diabetes improved LSEC porosity in young and old mice. Table 1
lists the effects of some recreational and medicinal drugs on
LSEC fenestrations.
Recreational Drugs
The effects of recreational drugs on LSEC porosity have not
been studied extensively (Table 1). The few studies performed
showed that the recreational drugs nicotine, ethanol, and cocaine
reduce LSEC porosity (Fraser et al., 1988; McCuskey et al., 1993),
while the psychedelic drug 2,5-Dimethoxy-4-iodoamphetamine
(DOI) increases porosity in LSEC in young and old rodents
(Cogger et al., 2014; Hunt et al., 2019). The effects on LSEC
porosity of other recreational/non-medicinal drugs such as
opioids, amphetamines, cannabis, and xanthines (such as caffeine
and theobromine) have, to the best of our knowledge, not
been studied. This would be an area of great interest, given
the extensive use of all of these among the general population.
This is exemplified by opioid use (which is also for medicinal
purposes) leading to the current “opioid epidemic” in the US
arising from the use of prescription oxycodone. Below is a
summary of the reported interactions of ethanol, cocaine, DOI,
and nicotine with LSEC.
Ethanol Given the wide use and general acceptance of alcohol,
and the suggested health benefits from moderate consumption,
it was discussed in the LSEC field whether moderate amounts
of alcohol could improve LSEC porosity and thereby lipoprotein
clearance. Of the studies (in vitro and in vivo) investigating
the effects of ethanol on LSEC, the majority were performed
in rats, but mice, baboons and human LSEC were studied
as well, with electron and atomic force microscopy methods
used as readout. Several studies reported that the fenestration
number was reduced, while the average fenestration diameter
was increased – this pattern was consistent in all the in vitro
studies (Mak and Lieber, 1984; Charles et al., 1986; Van Der
Smissen et al., 1986; Horn et al., 1987; Tanikawa et al., 1991;
McCuskey et al., 1993; Braet et al., 1994, 1995a, 1996c; de
Zanger et al., 1997) and with reduced porosity reported in
one study (Takashimizu et al., 1999). Takashimizu et al. (1999)
described reduction in fenestration diameter in rat during
in vivo continuous administration of ethanol into the portal vein,
and pre-treatment with BQ123 [an endothelin (ET) receptor
antagonist, see Table 2] reduced the effect of ethanol. One in vivo
study reported no changes in in the liver sinusoids in mice
after 9 weeks of ethanol feeding (McCuskey et al., 1993) but
ethanol in combination with cocaine caused the sinusoids to
become thickened and defenestrated. In other in vivo chronic
ethanol challenge studies (ethanol given to rats in food, or
human studies where biopsies were used), one rat study yielded
results consistent with the in vitro findings (reduced fenestration
number, increased diameter, reduced porosity) (Tanikawa et al.,
1991) while the other study reported reduced fenestration
diameter and number – this was the only study to find that the
diameter became smaller after ethanol challenge (Takashimizu
et al., 1999). In the human biopsy study, similar results were
obtained - chronic alcohol consumption (defined as > 60 g
alcohol intake every day for more than 3 years) resulted in
fewer fenestrations, diameters of between 50–300 nm and a
“visible difference” for porosity between the two groups. A study
in baboons showed that the duration of alcohol consumption
does not seem to have any impact on fenestrations (diameter
in second group (4–24 months alcohol consumption vs. 61–
112 months) was larger than control but smaller than first
group) (Mak and Lieber, 1984). In summary, ethanol at any dose
does not appear to improve LSEC porosity but rather has the
opposite effect.
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Ethanol +/- - - Van Der Smissen et al., 1986; Braet et al.,
1995a
SEM, TEM, in vitro
Mak and Lieber, 1984; Charles et al., 1986;
de Zanger et al., 1997
SEM, in vivo
Tanikawa et al., 1991; McCuskey et al.,
1993
TEM, in vivo
Horn et al., 1987; Takashimizu et al., 1999 SEM, in vivo
Braet et al., 1996c SEM, AFM, in vitro
Braet et al., 1994 SEM, in vitro
Ethanol +cocaine nd - - McCuskey et al., 1993 TEM, in vivo




+ +/- +/- Furrer et al., 2011; Cogger et al., 2014 SEM, in vivo
Hunt et al., 2019 SEM in vitro





G nd nd McCuskey et al., 2004 SEM, TEM, in vivo, in vitro
Acetaminophen/
paracetamol
G - - Ito et al., 2006b SEM, in vivo
Walker et al., 1983 SEM, TEM, in vivo
McCuskey et al., 2004; McCuskey, 2006 SEM, TEM, in vivo, in vitro
Amlodipine - + + Hunt et al., 2019 SEM, in vitro
Bosentan 0 + + Hunt et al., 2019 SEM, in vitro
Colchicine nd nd 0 Braet et al., 1996b TEM, in vitro
Disulfiram - nd + Bernier et al., 2020 SEM, in vivo
Metformin 0 + + Hunt et al., 2020 SEM, in vitro, in vivo
Alfaras et al., 2017 SEM, in vivo
Nicotinamide
mononucleotide (NMN)
0 + + Hunt et al., 2019 SEM, in vitro
Mao et al., 2019 dSTORM, in vitro
Cholesterol 0 0 0
Fraser et al., 1988, 1989
SEM, in vivo
Cholesterol +nicotine - - - Fraser et al., 1988 SEM, in vivo
Pantethine + cholesterol + + + Fraser et al., 1989 SEM, in vivo
Prostaglandin E1 + Oda et al., 1997 SEM, TEM, in vitro
Sildenafil 0/+ ++ + Hunt et al., 2019 SEM, in vitro
Mao et al., 2019 dSTORM, in vitro
Simvastatin + + + Hide et al., 2020 SEM, TEM, in vivo, SEM, in vitro
Venkatraman and Tucker-Kellogg, 2013;
Hunt et al., 2019
SEM, in vitro




+/0 +/0 +/0 Hunt et al., 2019 SEM, in vitro
“0,” no change; G, gaps; increase: “+,” <50%; “++,” 50–100%; “+++,” >100%; decrease: “-,“ <50%; “- -,” >50%; “- - -,” defenestration; “nd,” no data.
Cocaine is a widely used recreational drug with
vasoconstricting properties (Kim and Park, 2019), often
consumed in combination with alcohol. In a study from
McCuskey et al. (1993), mice challenged with cocaine alone
developed basement membrane deposition in the space of Disse,
some hepatocellular necrosis and slightly reduced centrilobular
sinusoid blood flow after 5 weeks, worsening up to 9 weeks
of challenge. In combination with ethanol these changes were
significantly exacerbated, in addition the sinusoidal endothelium
was thickened and defenestrated. Interestingly rats were more
resistant to these challenges, only developing some of these
changes at the end of the 15-week treatment regime. The
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Acetylcholine + nd nd Tsukada et al., 1986; Oda et al., 1990 SEM, in vivo, in vitro
Bethanechol + nd nd Oda et al., 1990 SEM, in vivo
Isoproterenol + nd nd Oda et al., 1990 SEM, in vivo, in vitro
Vasoactive intestinal
peptide (VIP)
+ nd nd Oda et al., 1990 SEM, in vivo
BQ-123 ++ nd - Watanabe et al., 2007 SEM, TEM, in vivo
Vasoconstrictors
Endothelin (ET) - - nd Oda et al., 1997;
Kamegaya et al., 2002
SEM, in vitro




Tsukada et al., 1986; Oda et al., 1990
SEM, in vivo, in vitro
Wisse et al., 1980 TEM, SEM, in vivo
Serotonin - nd nd Wisse et al., 1980;
Braet et al., 1995a
SEM, TEM, in vivo
Tanikawa et al., 1991 TEM, in vivo
Braet et al., 1996c SEM, AFM, in vitro
Kalle et al., 1997 AFM, in vitro
Pilocarpin - nd nd Wisse et al., 1980 TEM, SEM, in vivo
Adrenaline/
epinephrine




+ +++ ++ Funyu et al., 2001; Yokomori et al., 2003 SEM, in vitro
Carpenter et al., 2005 SEM, TEM, in vivo
Xie et al., 2012b SEM, in vivo, in vitro
Bone morphogenetic
protein (BMP)
Strain specific Strain specific Strain specific Desroches-Castan et al., 2019a,b (a) SEM, in vivo, in vitro




nd - nd Raines et al., 2011 TEM, in vivo
Liver X receptor (LXR) NA NA NA Xing et al., 2016 SEM, TEM, in vivo
Hedgehog (Hh)
signaling




+/- +/- +/- Herrnberger et al., 2014 SEM, TEM, in vivo
Auvinen et al., 2019 SEM, in vivo
“0,” no change; G, gaps; “nd,” no data; “NA,” not applicable. increase: “+,” <50%; “++,” 50–100%; “+++,” >100%; decrease: “-,” <50%; “- -,” >50%;
“- - -,” defenestration.
mechanism(s) by which cocaine and cocaine/ethanol challenge
elicit these changes remains to be elucidated, but in any case the
combined abuse of these drugs raises particular concerns with
regards to liver function.
Nicotine is the primary stimulant found in tobacco products
and is also a known vasoconstrictor (Benowitz and Burbank,
2016). Rats fed nicotine (dose equivalent to 50–100 cigarettes
per day in humans for 6 weeks) had LSEC porosity 40% of
that of controls, primarily as a function of reduced average
fenestration diameter and not of reduced fenestration number.
The nicotine treated animals also had near 50% higher serum
cholesterol than controls, probably as a consequence of reduced
LSEC porosity and thereby filtration of low-density lipoprotein
(LDL) out from the plasma of these animals (Fraser et al., 1988).
Nicotine and cholesterol fed animals had similar porosity and
diameter to nicotine-fed only animals. Together with results
from cholesterol-only fed animals (no visible changes), it suggests
that nicotine (but not cholesterol) has an effect on fenestrations
(Fraser et al., 1988). Other studies have shown that oral nicotine
induces an atherogenic lipoprotein profile (Cluette-Brown et al.,
1986) (including increased plasma LDL) and impairs plasma
LDL clearance (Hojnacki et al., 1986). The mechanism of action
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of nicotine in the LSEC context remains to be elucidated but
given the continued consumption of nicotine by humans in
various forms (e.g., tobacco products, e-cigarettes, and nicotine
supplements) this field warrants further study.
2,5-Dimethoxy-4-iodoamphetamine (DOI) is a substituted
amphetamine but is not a stimulant. It is a potent 5-
HT2A serotonin receptor agonist and is used recreationally
as a hallucinogenic drug (Lapoint et al., 2013). DOI induces
cutaneous vascular constriction in rabbits and rats, and this is
the suggested cause of hyperthermia resulting from serotonin
receptor stimulation (Blessing and Seaman, 2003). DOI has
reported beneficial effects on survival, liver regeneration and
LSEC morphology after partial hepatectomy (Tian et al., 2011).
Furrer et al. (2011) showed that in vivo DOI challenge increased
porosity in old but not young LSEC, and pre-treatment of old
mice with DOI prior to partial hepatectomy resulted in LSEC
with improved porosity (Furrer et al., 2011). However, the finding
that DOI improved porosity in aged LSEC is at odds with the
in vivo study of Cogger et al. (2014) who found that DOI
improved LSEC porosity in young but not old animals. Both
studies used SEM of tissue blocks to quantify fenestrations.
Further complicating the DOI story, SEM in vitro studies by Hunt
et al. (2019) on cultured LSEC from young and old mice revealed
that DOI challenge increased porosity in old but not young
LSEC, and this increase was most likely a function of increase
in both fenestration diameter and frequency. LSEC respond to
ligands for the 5-HT2 receptor, as they were reported to being
inhibited by ketanserin (a selective 5-HT2 receptor antagonist)
(Gatmaitan et al., 1996). The role of 5-HT2A and 2B receptors
was proposed as being involved in liver regeneration after liver
partial hepatectomy (Lesurtel et al., 2006). Similarly, the presence
of the 5HT2 receptor was later highlighted (Braet and Wisse,
2002; Braet, 2004). However, newly reported data showed that
known 5-HT receptor mRNAs were absent or at very low levels in
mouse, rat and human LSEC (Bhandari et al., 2020). It would thus
be of interest to resolve the question of DOI mediated effects, the
downstream mechanisms, and whether there is/are age-related
responses to DOI.
Medicinal Drugs
Pharmaceutical treatment and prevention of diseases is
constantly evolving, with an increasing number of novel
medicines entering the market every year. It was reported that
the EU retail pharmaceutical bill was around EUR 190 billion
in 2018 (OECD/European Union, 2020). Hepatic clearance and
metabolism are the basic routes of removing drugs from the
system. With decreased porosity prolonged circulation of drugs
increases their side effects. Nitric oxide (NO)-based drug therapy
was shown to have beneficial effects on the liver (Maslak et al.,
2015) and detailed studies on isolated cells confirm the positive
role of NO on fenestrated morphology in LSEC (Xie et al.,
2012b). Medicinal drugs with other intended targets may also
affect LSEC. A recent comparative study revealed the different
drug effects on fenestrations in LSEC in an age-related manner
(Hunt et al., 2019). Here we summarize the effects of various
medicines where fenestration number and size were reported.
Amlodipine is a calcium channel blocker used to treat
hypertension by dilating blood vessels to reduce blood pressure.
Amlodipine is also reported to increase endothelial NO (Xu
et al., 2002; Mason et al., 2014). Hunt et al. (2019) reported that
amlodipine increased the porosity in cultured LSEC from both
young and old animals and proposed that this increase was more
likely mediated by NO production than by calcium transport
blockage. This safe and commonly used blood pressure medicine
may thus also represent a pharmacological means to counteract
age-related defenestration.
Bosentan is a competitive antagonist of endothelin -A
and -B receptors, and is used to treat moderate pulmonary
hypertension, exerting its vasodilative effect via ET-A receptors
(Bacon et al., 1996). Endothelin-1 (ET-1) constricts fenestrations
pronouncedly and reduces porosity (Kamegaya et al., 2002), and
an ET-B receptor antagonist (BQ788) blocked this effect while
an ET-A receptor antagonist (BQ485) partially blocked the ET-
1 effect (Kamegaya et al., 2002). The ET-A receptor antagonist
BQ123 increased fenestration diameters, but caused major gaps
in sinusoidal cells and fusions of fenestrations within sieve plates
(Watanabe et al., 2007). Hunt et al. (2019) demonstrated that
lower doses of bosentan increased the porosity of LSEC from
old mice, while LSEC from younger mice were non-responsive.
Bosentan treatment of LSEC did not elicit an increase in NO
production in this study.
Colchicine is used as a therapy for gout and familial
Mediterranean fever. It decreases inflammation but its
pharmacotherapeutic mechanism of action is not fully
understood – its main mechanism of action is tubulin disruption
(Leung et al., 2015). Treatment of cultured rat LSEC with 200 µM
colchicine did not affect porosity while causing significant loss
of microtubules. Interestingly, the microtubules surrounding
sieve plates were still present (Braet et al., 1996b). Together
with the effect of taxol, which completely disrupts microtubules
and prevents cytochalasin-mediated induction of fenestrations,
this would suggest that tubulin architecture may have a crucial
role in LSEC porosity. Taxol (generic name paclitaxel) is a
microtubule-stabilizing drug used for the treatment of ovarian,
breast, and lung cancer, as well as Kaposi’s sarcoma (Weaver,
2014). Braet et al. (1996b) challenged cultured rat LSEC with
10 µM taxol and saw no change in porosity but reported an
overabundance of microtubules throughout the cytoplasm,
and alongside sieve plates. Moreover, treatment with 10 µM
taxol not only did not show a significant change in fenestration
number but pretreatment with taxol and two hours later with
cytochalasin B, inhibits the effect of the latter, i.e., the increase in
fenestration number is reduced in comparison to treatment with
cytochalasin B only.
Disulfiram (commercial name Antabuse) is a FDA approved
treatment for chronic alcohol addiction. It is an inhibitor of
acetaldehyde dehydrogenase and causes the feeling of a hangover
immediately upon alcohol consumption (Suh et al., 2006). It is an
inhibitor of the transcription factor NF-KB (Schreck et al., 1992)
which contributes to its anti-inflammatory properties. In the
experimental setting, the consumption of disulfiram was found
to normalize body weight in mice. It was also found to increase
the frequency of LSEC fenestrations in vivo, while decreasing
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their average diameter, resulting in no net increase in porosity in
mice and rats (Bernier et al., 2020). The mechanism(s) by which
disulfiram increases fenestration number remain to be elucidated.
Metformin is a first line treatment for type II diabetes for
serum glucose reduction (Maruthur et al., 2016). The mechanism
by which this drug exerts this effect remains to be elucidated,
but its primary target appears to be hepatocyte mitochondria
via inhibition of complex I of the respiratory chain. Inhibition
of gluconeogenesis (Owen et al., 2000) results in the activation
of the energy sensor AMP-activated protein kinase (AMPK)
leading to increased beta-oxidation of fatty acids. Alfaras et al.
(2017) tested 1% metformin administered every-other-week or
2-weeks-every-month to mice – these strategies being chosen to
avoid metformin induced nephrotoxicity. They found numerous
health benefits, particularly with the every-other-week regime,
and that the every-other-week approach also increased porosity
in LSEC in 2-year-old mice. Metformin (50 µM) increased LSEC
porosity in vitro in both young and old mice by 25 and 50%,
respectively (Hunt et al., 2020). This increase was due to increases
in fenestration frequency (20 and 50%, respectively) since the
fenestration diameter remained unchanged. In vivo studies in
mice treated with 0.1% metformin in their diet increased LSEC
porosity/fenestration frequency in young and old mice and
reduced the age-related loss of porosity in older mice by 50%
(Hunt et al., 2020). The mechanism of metformin action in LSEC,
with regards to fenestration status, remains to be established.
Nicotinamide mononucleotide (NMN) is a key nicotinamide
adenine dinucleotide (NAD+) intermediate. Long-term
administration of NMN is reported to mitigate age-related
physiological decline in mice (Mills et al., 2016), while short term
in vitro treatment reverses endothelial dysfunction (Mateuszuk
et al., 2020). NMN increased LSEC porosity in young and old
mice, via increased fenestration frequency, while the average
fenestration diameter was essentially unchanged (Hunt et al.,
2019). NMN challenge had no apparent effects on NOS or
cGMP levels in LSEC. Analysis of NMN challenged LSEC using
direct stochastical optical reconstruction microscopy (dSTORM)
revealed that the F-actin within LSEC was more condensed
and that the actin rings delineating fenestrations became more
pronounced (Mao et al., 2019). The mode of NMN action in
LSEC remains to be elucidated – NAD + associates with sirtuins
which play a critical role in multiple cellular functions (Imai and
Yoshino, 2013) so the study of the role of sirtuins in fenestration
biology is therefore warranted.
Pantethine is a derivative of vitamin B5 and has been
suggested as a therapy for reducing LDL levels (Rumberger
et al., 2011). Fraser et al. (1989) studied the effect of pantethine
in cholesterol fed rabbits. The pantethine plus cholesterol fed
animals had higher LSEC porosity, fenestration diameter and
frequency and lower total cholesterol than the animals fed
cholesterol alone. Cholesterol feeding had no effect on LSEC
porosity. The same result had been found in another study
(Fraser et al., 1988). Unfortunately, there was no group fed only
pantethine, so it would be interesting to establish if pantethine
alone increases LSEC porosity and if this can explain (in part) the
reported pantethine-mediated reduction of plasma LDL seen in
other studies (Fraser et al., 1989; Rumberger et al., 2011).
Paracetamol (also known as acetaminophen or commercially
as APAP, Panadol) is one of the most widely used analgesic
medicines. Acute overdoses of paracetamol can cause lethal liver
damage, due to the toxic metabolite N-acetyl-p-benzoquinone
imine (NAPQI) (Hodgman and Garrard, 2012). The consensus
is that, in vivo, paracetamol reduces rodent LSEC porosity both
via reduction of fenestration diameter and frequency at “clinical”
doses (Walker et al., 1983; McCuskey et al., 2004; McCuskey,
2006; Ito et al., 2006b). The in vitro effect of paracetamol on
LSEC was reported to be dependent on NAPQI induced depletion
of glutathione levels. In C3H mice, acetaminophen is directly
toxic to LSEC via P450 activation, while in Swiss Webster mice
the toxic effect on LSEC was indirectly driven by hepatocytes
(DeLeve et al., 1997). APAP-induced LSEC injury precedes
hepatocellular injury, supporting the hypothesis that LSECs are
an early and direct target for APAP toxicity. These findings also
suggest that reduced sinusoidal perfusion and increased Kupffer
cell activity contribute to the development of APAP-induced liver
injury (Ito et al., 2003). Although it was presented that large
gaps are formed and the porosity is reduced in LSEC in vivo, the
effects of paracetamol challenge on LSEC porosity in vitro have
not been reported.
Prostaglandin E1 (synthetic form: alprostadil) is a naturally
occurring eicosanoid used as vasodilator for several different
medical purposes (Kirtland, 1988). Applications include erectile
dysfunction (ED) treatment in men who do not respond
to PDE5 inhibitors (Hanchanale and Eardley, 2014) and the
opening of ductus arteriosus in neonates requiring heart
surgery (Singh and Mikrou, 2018). Prostaglandin E1 exerts
its effect via the production of nitric oxide which stimulates
soluble guanylyl cyclase to increase production of cyclic GMP
(cGMP) and/or by the direct binding of prostaglandin to
prostaglandin receptors, activating adenylyl cyclase to convert
ATP to cyclic AMP (cAMP). The end result is the same in either
pathway - decreased intracellular Ca2+ (Namkoong et al., 2005).
Oda et al. (1997) showed that prostaglandin E1 significantly
increased LSEC fenestration diameter in rat LSEC and also
caused partial fusion of some fenestrations within sieve plates.
They also reported increased Ca2+-ATPase on fenestral plasma
membrane after prostaglandin E1 challenge and postulated that
cytoplasmic Ca2+ efflux caused relaxation (and thereby dilation)
of LSEC fenestrations.
Sildenafil (also known as Viagra) is a vasoactive agent
used for the treatment of ED. It is a potent and selective
inhibitor of cGMP-specific phosphodiesterase (PDE) type 5,
due to its structural similarity to cGMP (Bender and Beavo,
2006). Sildenafil increases cGMP levels by inactivating PDEs
that metabolize cGMP to GMP as well as by blocking ABCC5
transport protein responsible for active efflux of cGMP from the
cell (Aronsen et al., 2014). cGMP is an intracellular mediator
of the NO pathway that can lead to relaxion of the vascular
smooth muscle (vasodilation) and thereby increase blood flow
(Denninger and Marletta, 1999). Hunt et al. (2019) challenged
LSEC from young (3–4 months) and old (18–25 months) mice
with sildenafil and found that porosity and fenestration frequency
(but not diameter) increased in LSEC from young and old mice.
Sildenafil also increased cGMP levels, NO synthesis and levels of
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phosphorylated nitric oxide synthase (pNOS). Mao et al. (2019)
also challenged LSEC (from young mice) and found that the
actin rings (which delineate fenestrations) and actin stress fibers
became more pronounced. In contrast to Hunt et al. (2019) and
Mao et al. (2019) found that sildenafil increased fenestration
diameter on average by 30%. This inconsistency might be due
to the methods used – the first study used SEM to score LSEC
morphology after dehydration, while the second study used
dSTORM on “wet” LSEC samples. Sildenafil (and other PDE and
ABC transporters inhibitors) may be an interesting therapeutic
option to increase LSEC porosity in the elderly.
Simvastatin is a cholesterol lowering agent. Its cholesterol
reducing action is via inhibition of 3-hydroxy-3-methylglutaryl
(HMG) coenzyme A reductase, the rate limiting enzyme
in cholesterol synthesis. Simvastatin also upregulates NO
levels suggesting vascular protective effects beyond cholesterol
reduction (de Sotomayor et al., 2005; Rikitake and Liao, 2005).
Hide et al. (2020) reported that simvastatin was somewhat
protective against warm ischemia reperfusion induced LSEC
defenestration in (male Wistar) rats, so simvastatin may
be able to provide a protective role in maintenance of
porosity. Venkatraman and Tucker-Kellogg (2013) showed that
simvastatin can antagonize Rho/ROCK (Rho-associated protein
kinase) signaling, protecting from the defenestration resulting
from activation of this pathway. Moreover, simvastatin treatment
led to increase on both porosity and fenestration frequency in
(male Wistar) rats. Interestingly these results in rats were not
replicated in mice. Findings of Hunt et al. (2019) in (male
C57/BL6) mice showed no significant changes in porosity or
fenestration frequency in young or old mice, and only a 20%
increase in mean diameter in the aged group. These findings
may suggest species dependent difference in the simvastatin
mechanism of action.
TRAIL [tumor necrosis factor (TNF)-related apoptosis-
inducing ligand] is a protein ligand reported to induce cell death
in transformed cells by binding to “death receptors” (Wiley et al.,
1995). It is also reported to induce NO production via eNOS
(Bartolo et al., 2015). Hunt et al. (2019) reported that LSEC
challenged with lower doses of TRAIL increased LSEC porosity
and fenestration frequency in young but not old mice. The lack of
TRAIL response of old mice LSEC could be explained by reduced
expression of TRAIL receptors in older mouse LSEC, but the
level of TRAIL receptor expression in young vs. old mice remains
to be determined.
Hormones and Other Agents Acting on
LSEC
LSEC and Vasoactive Agents
Vasoactive signaling molecules commonly act through a receptor
induced relaxation in the smooth muscle surrounding the
vasculature (Webb, 2003). Signaling is mostly mediated by the
NO/cGMP pathway and via intracellular calcium concentrations
(Chen et al., 2008). Crucially, whether a stimuli directs toward
constriction or relaxation will depend on the tissue specific
expression of certain receptors and the presence or absence of
inhibition of parallel pathways.
Hepatic sinusoids lack smooth muscle cells but can dilate
and contract responding to various vasoactive agents. Moreover,
according to the two main studies addressing this issue (Oda
et al., 1990; Gatmaitan et al., 1996), LSEC porosity and
fenestration diameter seem to correlate with vasodilation or
vasoconstriction (Table 2). These results suggest that vasodilators
and vasoconstrictors have a direct effect upon the fenestrations
of LSEC. The lack of super resolution techniques for living cells
was one of the main drawbacks at the time of these studies of
vasoactive agents’ effects on LSEC. It will be therefore beneficial
for the field investigate the role of vasoconstriction and dilation in
fenestration regulation using live cell imaging techniques, such as
AFM, SIM or stimulated emission depletion microscopy (STED).
Vasodilators
Acetylcholine is a vasodilator acting through the
cholinergic/muscarinic receptor (Sakai, 1980). In LSEC
acetylcholine dilates sinusoids increasing blood flow rate
and increasing fenestration diameter (Oda et al., 1990), when
administered intravenously. On the other hand, cholinergic
receptor agonists were also noted to cause narrowing of
the sinusoids: bethanechol, carbachol, and pilocarpine
applied topically to the liver caused constriction of the liver
microvasculature, but fenestrations were not quantified (Reilly
et al., 1982; McCuskey and Reilly, 1993). To further complicate
these findings, intravascular admission of pilocarpine decreased
while bethanechol increased the fenestration diameter. These
differences in the effects can be explained by the expression of
certain receptors responding to the same stimuli but having
contradictory effects, however, further studies are needed.
Bethanechol is already used as a therapy for postoperative and
postpartum non-obstructive urinary retention, it would therefore
be of interest to further study its effects on LSEC porosity (Oda
et al., 1990). Vasoactive intestinal peptide (VIP) is a class II
G-protein coupled receptor ligand (Umetsu et al., 2011). It
has multiple physiological effects including vasodilation and
increased gut motility during digestion (Iwasaki et al., 2019). VIP
was shown to dilate the sinusoids and fenestra, increasing blood
flow through the sinusoids which would enhance the uptake of
circulating nutrients after a meal (Oda et al., 1990). Isoprenaline
(also known as isoproterenol) is another vasodilating agent
acting as a β-adrenergic receptor agonist. This G-protein is
essential for cardiac function (reviewed in Wachter and Gilbert,
2012) and is used to treat bradycardia and (rarely) asthma.
The effect on LSEC follows that of other of vasodilating agents
increasing in both sinusoidal blood flow and fenestration
diameter (Oda et al., 1990).
Vasoconstrictors
Serotonin (also known as 5-HT) is a monoamine
neurotransmitter with numerous physiological functions
(Berger et al., 2009). Depending on the particular receptors
expressed in each vessel wall and surrounding smooth muscle
tissue, serotonin can cause vasoconstriction or vasodilation in
different vascular beds (Kaumann and Levy, 2006). In the liver,
serotonin constricts sinusoids and reduces fenestration size
(Wisse et al., 1980; Oda et al., 1990). Gatmaitan et al. (1996)
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showed that the effect is mediated by decreasing cAMP and
increasing intracellular calcium levels in a matter of seconds.
Endothelin (ET) is a vasoconstricting peptide that is produced
in the endothelium and plays an important role in vascular
homeostasis (Kawanabe and Nauli, 2011). In LSEC, it decreases
both the number and the size of fenestrations (Kamegaya et al.,
2002; Yokomori et al., 2006) and it reduces the blood-flow
through the sinusoids (Zhang et al., 1994). Many ET receptor
antagonists are used as an efficient treatment for hypertension.
ET-A receptor antagonist (BQ-123) treatment (but not ET-B
receptor antagonists) abolished ET induced defenestration and
contraction of fenestrations (Yokomori et al., 2006). Blocking ET-
1 activity in vivo by BQ-123 led to gap formation shown by SEM
and TEM (Watanabe et al., 2007). The α-adrenergic receptor
family mediates vasoconstriction and is coupled to guanine
nucleotide regulatory proteins (G-proteins) (reviewed in Ruffolo
and Hieble, 1994). α-adrenergic receptor agonists were found
to have different effects on LSEC, epinephrine (adrenaline)
decreased sinusoidal blood flow and contracted sinusoids
and LSEC fenestrations (Oda et al., 1990), while in another
study sinusoids were found slightly enlarged, and fenestrations
unchanged (Wisse et al., 1980). Norepinephrine (noradrenaline)
was found to contract sinusoids and fenestrations in both
studies (Wisse et al., 1980; Oda et al., 1990). Neuropeptide Y
(NPY), another vasoconstrictor generally coupled to G-protein
signaling, is involved in various physiological and homeostatic
processes (White, 1993) but also inhibits gastrointestinal motility
(Holzer et al., 2012). In LSEC, NPY constricts both sinusoid and
fenestrations (Oda et al., 1990).
Signaling and Fenestration Maintenance
One of the most challenging aspects of studying LSEC is the
dedifferentiation in vitro after cell extraction. LSEC lose their
characteristic porous morphology after just few days in culture,
significantly restricting time for experiments. There have been
many attempts to slow down, stop or reverse that process (Bravo
et al., 2019; Di Martino et al., 2019) but the main mechanism(s)
behind the loss of fenestrations remain unknown.
Vascular Endothelial Growth Factor (VEGF) is a hormone
that stimulates acetogenesis and angiogenesis (Apte et al., 2019).
In LSEC, VEGF has been shown to increase LSEC porosity
in vitro (Funyu et al., 2001; Yokomori et al., 2003) as well
as to prolong the fenestrated phenotype of cultured LSEC
in vitro (Xie et al., 2012b). Downregulation of VEGF signaling
has been associated with LSEC defenestration, capillarization
of sinusoids, and abnormal liver physiology (Carpenter et al.,
2005; DeLeve, 2015). DeLeve (2015) showed that VEGF promotes
fenestration formation/maintenance via NO-dependent and NO-
independent pathways. Moreover, VEGF can induce fenestration
like structures in other microvasculature, e.g., rat cremaster
capillary (Roberts and Palade, 1995).
Bone Morphogenetic Protein 9 (BMP9, also known as
GDF2) is a circulating endothelial quiescence factor (David
et al., 2008). In LSEC it has been indicated as necessary
for fenestration maintenance and treating cells with BMP9
prolonged fenestrated phenotype in cultured LSEC (Desroches-
Castan et al., 2019a). BMP9 knockouts in 129/Ola mice showed
very low fenestration frequency compared to WT, without
changes to diameters (Desroches-Castan et al., 2019a). However,
a follow up study using C57/Black mice did not confirm these
results (Desroches-Castan et al., 2019b).
Platelet derived growth factor B (PDGF) is a member
of the PDGF family of major mitogens for many cell types
(Fredriksson et al., 2004). Hepatic vascular permeability was
highly increased in PDGF-B retention deficient mice, with a
three-fold increase in FITC-dextran absorption and a more
fenestrated phenotype (Raines et al., 2011). PDGF-B signaling is
involved in pericyte recruitment and function, and stellate cell
activation (Raines et al., 2011).
Liver X receptor (LXR) is a nuclear receptor expressed in
a number of tissues, but with highest expression in the liver
(Willy et al., 1995). Oxysterols are natural ligands of LXR
and LXR deletion exacerbates CCl4 induced capillarization and
basement membrane deposition (Xing et al., 2016). LXR also
acts antagonistically on Hedgehog signaling (Hh) (Kim et al.,
2009), while LSEC produce and respond to Hh ligands and
use Hh signaling to regulate complex phenotypic changes that
occur during capillarization. Moreover, inhibition of Hh using
cyclopamine induced fenestration in vitro (Xie et al., 2012a).
Plasmalemma vesicle-associated protein (PLVAP) is
associated with angiogenesis and vascular permeability, with
less expression in barrier endothelium, and its expression is
stimulated by VEGF (Bosma et al., 2018). PLVAP was found to be
associated with a normally fenestrated phenotype, while PLVAP
deficient mice present extremely low porosity and accumulation
of collagen in the space of Disse (Herrnberger et al., 2014).
Auvinen et al. (2019) found that there was no difference in
number of fenestrations in PLVAP–/– mice, though their data
shows greater variability in the knockouts. Both studies used
SEM of tissue blocks for quantitative analysis of fenestrations.
The difference may relate to the methods used to attain the
knockouts raising the question of either knockouts being
too broad/non-specific or insufficient. PLVAP mutations are
associated with loss of fenestration diaphragms in other tissues
(such as small intestine) (Elkadri et al., 2015).
Lab Tools and Experimental Models
Experimental Animal Models for the Study of LSEC
Fenestrations
Liver sinusoidal endothelial cells are the first line of defense
in the liver and alterations in LSEC play a crucial role in the
development of many liver diseases such as fibrosis, cirrhosis,
or cancer (Gracia-Sancho et al., 2021) as well as in the age-
related conditions (Hunt et al., 2018). To better understand
this role, many animal models have been used. Challenge with
certain drugs can mimic the development of these diseases
and reduce the time and/or costs compared to waiting for
them to spontaneously occur in animals (Table 3). Although
the exact mechanism of action of many of these drugs is not
known, the outcome is similar enough to study and propose
possible treatments.
Cirrhosis is a pathological liver state characterized by
abnormalities in hepatic architecture such as loss of fenestrations
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Cytochalasin B 0/+ +++ +++ Braet et al., 1996a,b,c a/b AFM, SEM, in vitro
c SEM, TEM, in vitro
Steffan et al., 1987 SEM, TEM, in vitro
SEM, in vivo
Braet et al., 1995a TEM, in vitro
Zapotoczny et al., 2017b, 2019b AFM, in vitro live
Spector et al., 1999 FL, SEM, TEM, in vitro
Oda et al., 1993 SEM, TEM, in vitro
Van Der Smissen et al., 1986 TEM, in vitro, in vivo
Steffan et al., 1986 SEM, in vivo
Kalle et al., 1997 AFM, in vitro
Cytochalasin D 0/- + + Svistounov et al., 2012;
Hunt et al., 2019
SEM, in vitro
Dihydrohalichondramide - nd ++ Braet et al., 2002 SEM, in vitro
Halihondramide - nd ++ Braet et al., 2002 SEM, in vitro
Jasplakinolide - nd + Zapotoczny et al., 2019b AFM, in vitro live
Braet et al., 1998 SEM, TEM, in vitro
Spector et al., 1999 FL, in vitro
Latrunculin A 0 nd ++ Braet et al., 1996a SEM, TEM, in vitro
Spector et al., 1999 FL, in vitro
Braet et al., 1997 SEM, in vitro
Misakinolide - nd ++ Braet et al., 1998, 1999; Spector et al.,
1999
SEM, TEM, in vitro
Swinholide A - - nd +++ Braet et al., 1998, 1999; Spector et al.,
1999
SEM, TEM, in vitro
Disease models
Dimethyl nitrosamine (DMN) - - - nd Fraser et al., 1991, 1995b; Rogers et al.,
1992; Tamba-Lebbie et al., 1993
SEM, in vivo
Endotoxin/LPS -/G - -/0 -
Dobbs et al., 1994; Fraser et al., 1995b
SEM, in vivo
Frenzel et al., 1977; Ito et al., 2006a
SEM, TEM, in vivo
Sasaoki et al., 1995 SEM, in vitro
Galactosamine + endotoxin G nd - Ito et al., 2006a SEM, TEM, in vivo
Galactosamine + endotoxin
+ matrix metaloproteinase
0 nd 0 Ito et al., 2006a SEM, TEM, in vivo
Monocrotaline G nd - - DeLeve et al., 1999 SEM, TEM, in vivo
DeLeve et al., 2003a,b SEM, in vivo
Monocrotaline
+ V-PYRRO/NO
0 0 nd DeLeve et al., 2003b SEM, in vivo
Poloxamer 407 nd nd - - Cogger et al., 2006 SEM, TEM, in vitro, in vivo
Pyocyanin nd - - nd Cheluvappa et al., 2007 SEM, in vitro
Thioacetamide (TAA) - - - nd Mori et al., 1993a,b SEM, TEM, in vivo
Xie et al., 2012b SEM, in vivo
Other
Superoxide anion (SOA)
and nitric oxide NO
G nd - Deaciuc et al., 1999 SEM, TEM, in vivo
7 keto cholesterol (7KC) + + + Svistounov et al., 2012; Hunt et al., 2019 SEM, in vitro
Antimycin A nd - - - - Zapotoczny et al., 2017b AFM, in vitro live
Braet et al., 2003 SEM, TEM, in vitro
Arsenic nd - - nd Straub et al., 2008 SEM, TEM, in vitro, in vivo
C3 transferase + + nd Yokomori et al., 2004 SEM, TEM, in vitro
(Continued)
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Calcium ionophore - nd 0 Zapotoczny et al., 2019a AFM, in vitro
Oda et al., 1993 SEM, TEM, in vivo
Calmodulin agonist w7 + nd nd Oda et al., 1993 SEM, TEM, in vitro
Cyclopamine nd + nd Xie et al., 2012a SEM, in vitro
Diamide nd nd - - - Zapotoczny et al., 2019a AFM, in vitro live
Hydrogen peroxide +/G - -/+ - Cogger et al., 2001 SEM, TEM, in vivo
Straub et al., 2008 SEM, TEM, in vitro, in vivo
Iodoacetic acid nd nd + Zapotoczny et al., 2019a AFM, in vitro live
Lysophosphatic acid (LPA) - nd - - Yokomori et al., 2004 SEM, TEM, in vitro
Phorbol myristate acetate
(PMA)
0 nd - de Zanger et al., 1997 SEM, in vitro
S-nitroso-N-acetyl
penicillamine (SNAP)
G nd 0 Deaciuc et al., 1999 SEM, TEM, in vivo
Staurosporine 0 nd - de Zanger et al., 1997 SEM, in vitro
Tert-butyl hydroperoxide G + 0 Cogger et al., 2004 SEM, TEM, in vitro, in vivo
Triton x100 0 - - nd Svistounov et al., 2012 SEM, in vitro
Trombospondin 1 nd - - - - Venkatraman and Tucker-Kellogg, 2013 SEM, in vitro
“0,” no change; G, gaps; nd, no data; increase: “+,” <50%; “++,” 50–100%; “+++,” >100%; decrease: “-,“ <50%; “- -,” >50%; “- - -,” defenestration.
(defenestration) and the build-up of basement membrane formed
from collagen deposition in the space of Disse. Interestingly, the
first stages of capillarization and defenestration was reported to
be reversible prior to the deposition of collagen and formation
of a basement membrane which indicates progression from
fibrosis to cirrhosis (Xie et al., 2012b). Drugs such as dimethyl
nitrosamine (DMN) or thioacetamide (TAA) are used to
induce cirrhotic morphology in LSEC in animal models. Chronic
admission of DMN (Fraser et al., 1991; Tamba-Lebbie et al.,
1993) and TAA (Mori et al., 1993b; Xie et al., 2012b) was
shown to lead to the loss of fenestrations, however the precise
mechanism(s) behind this remains unknown. It was suggested
that soluble guanine cyclase (sGC) is a crucial element of
signaling necessary to maintain fenestrated LSEC morphology.
sGC activation normalizes LSEC phenotype and completely
prevents progression of fibrosis despite ongoing TAA exposure,
so the limiting defect responsible for capillarization in this
model of cirrhosis was in the NO/sGC/cGMP pathway (Xie
et al., 2012b). Defenestration is an important step not only in
cirrhosis and fibrosis but also with aging and its development
and has an impact on the whole organism. Lack of filtration of
chylomicrons and chylomicron remnants leads to hyperlipidemia
(Rogers et al., 1992). Cogger et al. (2006) showed that poloxamer
407, a synthetic surfactant causes dramatic defenestration and
massive hyperlipidemia. This finding suggests a direct role of
LSEC porosity in the lipid clearance in the liver.
Monocrotaline has been used to a model hepatic veno-
occlusive disease (DeLeve et al., 1999) and sinusoidal obstruction
syndrome (SOS) (DeLeve et al., 2003a,b). Toxic effects were
observed only in LSEC but not in hepatocytes nor in other
parts of the endothelium. LSEC metabolize monocrotaline by
conjugation to glutathione and detoxify to pyrrolic metabolite.
It is believed to be a stable reproducible model resulting
in a decreased number of fenestrations, gap formation and
discontinuous sinusoid occurrence (DeLeve et al., 1999). It is an
important reminder that LSEC also can metabolize drugs and it
is not only the hepatocytes that have this function in the liver.
Galactosamine, together with endotoxin or TNF, causes
gap formation in the sinusoids and can be used to study
the neutrophil extravasation in the acute inflammatory tissue
injury (Ito et al., 2006a). It was shown that inhibition of
matrix metalloproteinases, which are involved in gap formation,
reduces the neutrophil accumulation in the sinusoids. Bacterial
endotoxin alone plays a role in the pathogenesis of cirrhosis,
decreasing both number and diameter of fenestrations (Dobbs
et al., 1994). Other bacterial toxins, such as pyocyanin or LPS,
are used in studies of post-transplantation complications such
as sepsis or ischemia-reperfusion injury. Pyocyanin treatment
decreases porosity by its effects on the frequency of fenestrations
and can be prevented by addition of catalase. This result
suggests that the mechanism involves hydrogen peroxide–
induced oxidative stress (Cheluvappa et al., 2007).
Another bacterial toxin, Clostridium botulinum C3-like
transferase (C3-transferase), together with lysophosphatic acid
(LPA) was tested in a study from 2004. C3-transferase is a rho
inhibitor, while LPA is a rho stimulator. Rho was found to
be an important regulator of the actin cytoskeleton and was
therefore tested for its influence on fenestration and LSEC in
general. The in vitro experiments on rat LSEC showed dilation
and fusion of fenestrations after treatment with C3-transferase,
while contraction occurred when the cells were treated with LPA.
Additionally LPA caused an increase in F-actin stress fiber and
actin microfilaments, while C3-transferase treatment showed the
opposite (Yokomori et al., 2004).
Several models of experimental liver injury show similar
morphological alterations, including gaps and ruptured
sinusoids. Deaciuc et al. (1999) showed that these early changes
can be mediated by the free radical species. The in vitro treatment
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of rat LSEC with superoxide anion or nitric oxide resemble the
observations from in vivo experiments with various hepatotoxins.
Treatment with hydrogen peroxide also increased fenestration
diameter and decreased fenestration number (Cogger et al.,
2001). High porosity values can be misleading in the studies
where gap formation is observed so measurement of all three
morphology parameters should be considered. Straub et al.
(2008) presented that effect of low doses of arsenic, mimicking
water contamination levels, also act through reactive oxygen
species (ROS) generated by NADPH oxidase (NOX). This
mechanism was confirmed by the protective (against arsenite)
results from NOX deficient mice and use of NOX inhibitors.
Cytoskeleton Disruptors
Numerous agents acting on the actin cytoskeleton have
significant effects on fenestration (Table 3). Two main groups
include marine sponge- and mushroom-derived toxins.
Relatively well-known mechanisms of action of these toxins
allowed the study of the link between actin cytoskeleton
and fenestrae. An extensive chapter from Braet et al. (2008),
provides an overview on the in vitro effects of actin binding
agents such as cytochalasin B, latrunculin A, jasplakinolide
A, swinholide A, misakinolide A, halichondramide, and
dihydrohalichondramide. Despite different mechanisms of
promoting/inhibiting actin polymerization or fiber stabilization,
all drugs result in an increase of fenestration number. The most
surprising finding is the effects of jasplakinolide which promotes
polymerization and stabilization of actin in other cells, but in
LSEC no such effect was shown. Instead, the loss of fibers and
accumulation of actin in single spots occurs within minutes of
jasplakinolide treatment (Spector et al., 1999). These structures,
described as ‘actin dots,’ are not fully understood, but they
resemble recently described actin asters which may be connected
with lipid raft reorganization (Fritzsche et al., 2017). There is
an ongoing discussion about the specificity of those agents for
actin. For example, cytochalasin B (but not D) was shown to
influence transport of glucose across cell membranes and its
overall effect can be influenced by changes in glycolysis and
metabolism (Kapoor et al., 2016). Iodoacetic acid acts on both
actin and spectrin and was shown to decrease stress filament
formation. Moreover, it caused an increase in porosity and
rapid opening and closing of fenestrations (Zapotoczny et al.,
2019a). Nevertheless, agents acting on the actin cytoskeleton
remain the most important tools for studying fenestration
structure and dynamics.
Other Agents Affecting Fenestrations
Svistounov et al. (2012) emphasized the importance of lipid
membrane stability and lipid rafts on LSEC morphology.
Surfactants such as Triton X100 or poloxamer showed
destabilization of the cell membrane and promotion of lipid
raft formation which resulted in a decrease or even complete
ablation of fenestrations. Moreover, the reduction of lipid raft
formation by 7 keto-cholesterol (7KC) increased the number
of fenestrations showing the connection between fenestration
structure, actin and cell membrane (Hunt et al., 2019).
Thrombospondin 1 (TSP) is a matrix glycoprotein with
pro-fibrotic effects. In a study from 2013 (Venkatraman and
Tucker-Kellogg, 2013) it was shown to cause dose-dependent
defenestration in LSECs at 100 ng/mL. The authors additionally
showed that the CD47-binding fragment of TSP1, p4N1 – which
has anti-angiogenic effects in endothelial cells, also induces
defenestration in LSECs.
The influence of phorbol myristate acetate (PMA), a protein-
kinase-C (PKC) activator and staurosporine, a PKC inhibitor,
on LSEC have been examined by de Zanger et al. (1997). The
in vitro treatment of rat cells for 2–7 days resulted in a decrease in
porosity, due to the decrease in fenestration number without any
observable change in fenestration diameter, when treated with
PMA. However, despite the decrease in porosity, PMA improves
LSEC cultures in terms of viability and purit, and fenestrated
morphology was maintained after 7 days (de Zanger et al., 1997).
Treatment with staurosporine or PMA and staurosporine showed
enlarged fenestrations, gap formation and a decrease in porosity.
The authors concluded that PMA acts on LSEC through PKC
based on the staurosporine treatment neutralizing the PMA
treatment effects.
Deaciuc et al. (1999) tested rat livers challenged with
superoxide anion [S-nitroso-N-acetyl penicillamine (SNAP)]
and nitric oxide [xanthine oxidase plus hypoxanthine
(XO + HX)] generating substances. They theorized that
early morphological LSEC alterations associated with liver injury
are influenced by free radical species. When they perfused the rat
livers with SNAP, they found a suppression of hyaluronan uptake
(a test of LSEC endocytosis capacity) and the formation/creation
of large gaps in LSEC morphology, sometimes instead of sieve
plates, and sometimes together with fenestrations present
in sieve plates.
MECHANISMS
As discussed above, a variety of agents have been tested so
far showing their effect on fenestrae. Some of the agents
changed the number of fenestrations, while others alter their
diameters or distribution (gathered in sieve plates or individual
fenestrations), including the formation of gaps. However, the
clear understanding of why individual drugs have their effects
on LSEC is still lacking. The main reason is that many drugs
have cross-effects at the cellular level, affecting more than one
cellular mechanism/pathway, including the rearrangement of
cytoskeleton. Therefore, it is challenging to predict how a drug
will work on LSEC fenestrations.
A thorough analysis of the effects of a variety of agents
changing porosity, fenestration frequency, and fenestration
diameters (including gap formation) resulted in four
different hypotheses. These independent but overlapping
ideas describe the possible mechanisms behind fenestration
structure and dynamics.
(I) Actin (de)polymerization regulates the number of
fenestrations (Braet et al., 1996b; Spector et al., 1999; Braet
and Wisse, 2002; Mönkemöller et al., 2015). The hypothesis
was discussed in Braet et al. (1995a), Braet et al. (1996b)
and has been developed over the years. It was presented
that the cytoskeleton plays a crucial role in the porosity
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of LSEC. Fenestrae-associated cytoskeleton rings (FACR)
surround each fenestration and sieve plate-associated
cytoskeleton surround sieve plates (Braet et al., 1995b).
The application of actin (de)polymerization targeting
drugs revealed the direct connection between actin
cytoskeleton and fenestration number in LSEC (Spector
et al., 1999; Carpenter et al., 2005). However, the disruption
of actin does not destroy fenestration structure, which
indicated the complex structure of FACR. Later it was
reported that actin filaments surround each fenestration
within a sieve plate (Mönkemöller et al., 2015).
(II) Calcium ions regulate the diameter of fenestrations.
This second hypothesis was summed up in 2002
(Braet and Wisse, 2002). It is mainly based on the
research of Oda and Yokomori presenting the role of
calcium/calmodulin/actomyosin in the contractility
of fenestration diameters (Oda et al., 1990; Yokomori
et al., 2004). The regulation of myosin light chain
(MLC) phosphorylation occurs via calcium-calmodulin
signaling. Further it was suggested that MLC kinase and
phosphatase may exert different effects on cell morphology
(Yokomori et al., 2004).
(III) Regulation of fenestrations depends on lipid rafts. The sieve-
raft hypothesis assumes that fenestrations are formed in
the flat areas of the cell periphery, in between lipid rafts,
where the cell membrane is more flexible and more prone
to shape changes (Svistounov et al., 2012). Also, other ways
in which lipid rafts can be connected with fenestration
were proposed, such as influence on signal transduction or
indirect regulation of some signaling pathways.
(IV) Spectrin is involved in the open versus closed state
of fenestration. The hypothesis decouples the direct
actin regulation from the number of fenestrations.
Instead, the interplay between the membrane
scaffold and actin cytoskeleton is responsible for
the opening of the fenestration within the actin ring
(Zapotoczny et al., 2019a).
All the above hypotheses do not exclude each other and
only emphasize how complicated the mechanisms regulating the
number, shape, and size of fenestrations can be. In the following
subsections we will focus on the physiological regulation
of number and size of fenestrations, apart from the direct
(often toxic) effect of actin disturbing drugs (described above).
The analysis of different agents acting on LSEC fenestrations
leads to the conclusion that the phosphorylation of myosin
light chain (MLC) is the core of various pathways regulating
actin (de)polymerization. Calcium dependent and independent
activation (phosphorylation) of MLC and release of actin binding
proteins (such as tropomodulin, tropomyosin, caldesmon) leads
to contraction of fenestrations and decrease in the number
of fenestrations, while MLC dephosphorylation leads to the
relaxation of MLC and promotes more fenestrated morphology
of LSEC. The local balances regulating the levels of calcium,
ROS, or NO in different parts of the cell ensure active control
over the dynamics of fenestrated LSEC. The regulation covers
the (de)activation of membrane proteins which may affect
actin association to the membrane. Finally, the oxidative state
of membrane cytoskeleton and lipid rafts distribution are
additionally (passively or actively) involved in this regulation.
Cytoskeleton
SEM and TEM allowed visualization of the fenestrae-associated
cytoskeleton rings (FACR) in LSEC (Braet et al., 1996b).
Preparations of “ghost” cells, after removing cell membrane with
detergent, revealed a network of filaments associated with sieve
plates surrounded by thicker filaments. Precise identification
was not possible, but the high resolution of those techniques
allowed diameter measurements suggesting a mesh of actin
fibers surrounded by microtubules. The gap in the chemical
information has been filled with super resolution fluorescence
microscopy. Mönkemöller et al. (2015) showed the first direct
correlation between the localization of cell membrane and actin
around fenestration, using SIM. Recently, FACR structures could
be also visualized in high resolution using AFM and dSTORM
(Zapotoczny et al., 2017b, 2019a). It was also presented that the
complete actin ring is necessary to form an open pore within a
FACR (Zapotoczny et al., 2019a).
Cytoskeleton remodeling that influences the number of
fenestrations was demonstrated for live LSEC. During the first
hours after isolation LSEC spread on the substrate, opening
and closing individual fenestrations and whole sieve plates. It
indicated that fenestrations are not preserved from the in vivo
to the in vitro state and their formation and closing is dynamic
as previously suggested (Braet and Wisse, 2012). With time, the
dynamics of fenestrations was shown to be slower (Zapotoczny
et al., 2020). Still, fenestrations in isolated LSEC were shown to
freely migrate several micrometers, and changing their diameter
up to 200% during their∼ 20 min lifespan.
Interesting labyrinth like structures have been observed
in vitro in the proximity of the perinuclear area of LSEC (Braet
et al., 2009). Some fenestrations form three dimensional multi-
folded tunnels that are not always passing through the cell which
contradicts the sieving role of LSEC. One possible explanation
could be that these structures are caused by the cell isolation
process because they have not been observed in vivo (in tissue
samples). After digestion of the liver with Liberase/collagenase
cells are detached from each other, perhaps disrupting parts
of their cytoskeleton in a way that can be beyond repair
after reattachment in vitro. Another explanation assumes that
microfilament-disruption induces translocation of pre-existing
three-dimensional organized fenestrae forming centers (FFCs)
from the perinuclear area toward the peripheral cytoplasm (Braet
et al., 1998, 2007). Recently, the formation of FFC was shown
in live LSEC. It was confirmed that FFC are involved in the
rapid increase in fenestration number, both in control and
drug treated LSEC.
The importance of the actin cytoskeleton and the structure
of FACR was confirmed by the dramatic effects of any agent
directly affecting actin. Actin disruptors (see Table 3 and
Figure 3) were shown to rapidly induce the formation of
new fenestrations (up to 300% porosity increase in 30 min
by cytochalasin B) despite different mechanisms of actin
depolymerization (Steffan et al., 1987; Zapotoczny et al., 2017b).
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Other drugs that indirectly cause actin depolymerization, such
as iodoacetic acid, metformin or sildenafil, also resulted in the
increase in fenestration number (Hunt et al., 2019; Zapotoczny
et al., 2019a). Altogether, agents acting on actin cytoskeleton
remain the most important tools in studying fenestration
structure and dynamics.
Understanding the mode of action of actin disturbing
agents may help us reveal fenestration structure. Actin fibers
are regulated by a set of proteins such as profilin, gelsolin,
or cofilin that create the dynamic, out-of-equilibrium state.
Every actin-binding protein, regardless of the location of its
actin-binding site, influences the adenine nucleotide exchange
rate of actin and the ratio of G (monomer/globular) and F
(polymerized/filamentous) actin (Figure 3). Control over that
process is maintained by many signaling pathways allowing
LSEC to adjust the morphology according to internal and
external stimuli. Actin disrupting agents act similarly to those
controlling proteins. However, they lack control or feedback loop
systems therefore result in rapid and dramatic changes. The
importance of the controlled signaling is especially visible in
prolonged in vitro LSEC culture where changes in cytoskeleton,
such as stress fiber formation and fenestration disappearance,
occur (Yokomori et al., 2004). However, the direct relationship
between the actin polymerization into the thick stress fibers
and the decrease in the number of fenestrations needs
to be evaluated.
In fact, actin is the only demonstrated protein that was
validated to have a direct impact on the number of fenestrations.
Therefore, we discuss the various signaling pathways leading to
actin and actin related proteins and the ways to affect them to
observe the desired effect on fenestrations in the next section.
MLC Phosphorylation – The Core of the
Fenestration’s Regulation
Myosins convert ATP to create a mechanical force on actin.
Created tension in actomyosin cytoskeleton is necessary for
number of cellular processes, including cell motility, cytokinesis
and intracellular trafficking (Brito and Sousa, 2020). The myosins
contain a neck region allowing to bind myosin light chain
(MLC) domains, which are regulated by the phosphorylation
and dephosphorylation via MLCK and MLCP respectively. In its
phosphorylated/active form, MLC results in activation of ATP
dependent myosin heavy chain binding to f-actin, which creates
an active contractile force. With 30 classes of molecular motors
in myosin superfamily regulating variety of cellular processes
(Brito and Sousa, 2020) several reports have been dedicated to
the role of MLC in the regulation of fenestration diameters. In
the following subsections we focused on the cellular machinery
involved in the regulation of MLC phosphorylation via calcium,
NO, and ROS pathways.
Lipid Rafts
The existence and role of lipid rafts has caused divisions
in the scientific community in recent years and during The
Keystone Symposium on Lipid Rafts and Cell Function (2006)
the following definition was adopted: “Membrane rafts are
small (10–200 nm), heterogeneous, highly dynamic, sterol- and
sphingolipid-enriched domains that compartmentalize cellular
processes. Small rafts can sometimes be stabilized to form
larger platforms through protein-protein and protein–lipid
interactions.” The role of lipid rafts in fenestrations structure
and dynamics was studied only recently (Svistounov et al., 2012)
and then the hypothesis of sieve-raft regulation of fenestrations
was proposed by Cogger et al. (2013). Visualization with SIM
revealed that rafts are not present inside sieve plates but
rather surround them in an inverse distribution (Svistounov
et al., 2012). Fenestrations are formed in the flat, non-raft
lipid-disordered regions and are prone to changes in raft
organization. 7 keto cholesterol (7KC) increases lipid ordered,
non-raft regions and thus promotes fenestration formation while
detergent Triton X-100 increases the relative area of raft rich
regions and decreases fenestration number (Svistounov et al.,
2012; Hunt et al., 2018) (causing complete defenestration at
high Triton X-100 concentrations). High doses of 7KC caused
gap formation and retraction of cell membrane, which can
be explained by deficits in cell membranes after depletion of
rafts. Another detergent, poloxamer 407, was also reported to
elicit massive defenestration of LSEC (Cogger et al., 2006).
Interestingly, pre-treatment with Triton X-100 (increases rafts)
abrogated the effect of cytochalasin D and no increase in porosity
was observed (Svistounov et al., 2012). This result elucidates
the tight connection between rafts and actin cytoskeleton
in fenestration structure and/or dynamics. However, it was
reported that the lipid rafts in biological membranes induced by
detergents may not fully resemble the normal functional rafts
(Heerklotz, 2002).
Rafts are enriched in sphingolipids and cholesterol which
engenders membrane stability and provides a platform for many
membrane proteins that may contribute to their connection to
the actin cytoskeleton (Viola and Gupta, 2007). The anchoring
of actin to the lipid rafts was suggested to be realized through
the FERM domain of ERM proteins and talin (Chichili and
Rodgers, 2009), as well as adducin (Yang et al., 2018) and spectrin
(Ciana et al., 2011). Functional rafts may not be steady-state
phenomena; they might form, grow, cluster or break up, shrink,
and vanish according to functional requirements, regulated by
rather subtle changes in the activity (disordering or ordering)
of membrane compounds (Heerklotz, 2002). These properties
might be connected with the dynamic nature of fenestrations
and LSEC’s ability to rapidly respond via morphology changes.
The amount of lipid rafts may also have an indirect effect
on fenestrations, through interactions independent of actin.
It has been reported that ABC transporters, which decrease
intracellular cGMP levels by its efflux, work less efficiently out
of raft regions (Klappe et al., 2009). cGMP is an important
signaling molecule that acts on fenestrations through PKG,
decreasing intracellular calcium and promoting relaxation, both
of which are connected with growing fenestration number.
Lipid rafts may also affect many signal transduction pathways
in the cell by serving as platforms to bring receptors into
proximity with activating kinases, scaffolding proteins, and
adaptor molecules that are constituent residents of lipid rafts
(Rauch and Fackler, 2007).
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FIGURE 3 | Schematic representation of the effects of actin disrupting drugs on actin filaments. Depolymerization of the barbed end of the actin filament is inhibited
by CYT, MIS, and HALI which cap the barbed end, and by PHAL and JASP which attach from the side, additionally stabilizing the fiber. Latrunculin promotes
depolymerization by specific sequestration of monomeric actin. Polymerization is stimulated by JASP which also binds competitively to PHAL. Barbed end
polymerization is inhibited by CYT, LAT, SWA, and MIS. Both MIS and SWA bind two actin monomers, however only MIS caps the barbed end. HALI and SWA
stimulate severing of the actin filament. CYT, cytochalasin; HALI, halihondramide; JASP, jasplakinolide; LAT, latrunculin; MIS, misakinolide; PHAL, phalloidin; SWA,
swinholide.
Spectrin
It was reported that only completely closed FACR structures
contained fenestrations in the open state (Zapotoczny et al.,
2019a). It was proposed that spectrin arranges actin to form a
ring-like structure. Although the actin cytoskeleton is important
part of fenestration structure, the membrane scaffold has a role
in the regulation of opening of fenestration within FACR. In the
spectrin-actin hypothesis, fenestrations can be opened if the cell
height does not exceed 300–400 nm, which is double the length
of the spectrin unit (Zapotoczny et al., 2019a). The proposed
mechanism is based on the observation of both open and
closed fenestrations within actin rings in live LSEC in vitro. The
switch between the open and closed state was pharmacologically
induced. The actin-spectrin complexes are strong enough to
allow migration of the individual fenestrations across the cell
membrane. Moreover, it can explain, why actin depolymerizing
agents induce new fenestrations: spectrin can arrange short actin
fibers to form ring like structures, and decreased cell height allows
spectrin units to bind, forming new FACRs. In 2020, the role
of actin/fodrin (non-erythroidal spectrin) was reported to be
required in fenestration biogenesis in the endothelioma cell line
bEND5, in which fenestrations can be induced pharmacologically
(Ju et al., 2020). Authors showed a close association between
beta actin and spectrin. Moreover, they reported that knockout
of alpha spectrin resulted in 10-fold decrease in the number
of fenestrations. Nevertheless, despite the increasing interest in
this membrane cytoskeletal protein the knowledge of membrane
skeleton regulation in endothelial cells is poorly understood.
Regulation via Ca2+
The role of calcium in the regulation of fenestration diameters
was discussed by Braet and Wisse (2002). The serotonin induced
influx of calcium was described to cause calcium-calmodulin
dependent phosphorylation of MLCK decreasing the size of
fenestrae, denoted as contraction. The reverse effect remained
as speculation. Later, Yokomori et al. (2004) summarized
that calcium influx affected not only MLCK, but also Rho
activity. Thus, calcium can affect both MLCK and ROCK
dependent phosphorylation of MLC. The authors presented
results of LPA and C3 transferase, causing fenestration closing
and dilating respectively, indicating that they act through MLC
phosphorylation. In the Figure 4 we extended the possible
regulation of MLC phosphorylation, based on the current
state of knowledge. MLC is activated by the calcium mediated
phosphorylation via myosin light chain kinase (MLCK) (Rigor
et al., 2013). The activity of MLCK is increased by Ca2+-
calmodulin binding and by phosphorylation by protein kinase C
(PKC). PKC can also further promote MLC phosphorylation by
inhibition of MLCP, however, this pathway was not confirmed
in endothelium (Somlyo and Somlyo, 2000). The activation of
MLCK can be hampered by the cAMP dependent kinase –
protein kinase A (PKA). PKA binds to the similar region
of MLCK to the Ca2+-calmodulin complex binding domain,
hampering calcium dependent MLC phosphorylation. However,
the activation of MLC is not sufficient to create a contractile
force of the actomyosin complex. The actin binding proteins
ensure additional control. Actin is stabilized by e.g., tropomyosin,
tropomodulin, caldesmon, or calpain. The release of these
proteins from actin is controlled in a calcium-concentration-
dependent manner, allowing myosin to reach actin (Hepler,
2016). Moreover, the activation of actin polymerization processes,
e.g., by gelsolin, profilin or cofilin is also calcium dependent
and results in an increase in actin polymerization. The calcium
level, regulated by calcium membrane channels and pumps or
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FIGURE 4 | This scheme represents an attempt in unifying the proposed hypotheses of mechanisms behind the structure and dynamics of fenestrations. Various
signaling pathways involved in the regulation of fenestrations in LSEC are based on the studies of LSEC (or other endothelial cells). The drugs with known
mechanisms of action and reported to affect fenestrations are summarized in Table 4.
by endoplasmic reticulum release, causes a cascade of cellular
mechanisms driving local changes in the cytoskeleton. These
changes vary in different cells and the details of these processes
is beyond the scope of this review. The contraction of actomyosin
is permanent. It means that it must be actively undone to ensure
actomyosin relaxation. The balance of (de)phosphorylation of
MLC is maintained by MLC phosphatase (MLCP). The enzyme
activity is independent of the calcium plasma concentration
(Álvarez-Santos et al., 2020). In addition to the role in the
dephosphorylation of MLC, it exhibits phosphatase activity
toward other proteins, such as ankyrin, adducin, Tau, merlin,
calcineurin-A, interleukin-16, Rb, moezin, and ezrin (Kiss et al.,
2019). Inhibition of MLCP (MYPT1 complex) by activation of
the RhoA/ROCK pathway, results in indirect increase in the level
of phosphorylated MLC and an increase in/of the contractile
forces. PKA, PKG, and PKC also cause phosphorylation of
MLCP. However, a recent study showed that in contrast to
the RhoA/ROCK pathway, PKG- induced phosphorylation has
no effect on MLCP activity (MacDonald and Walsh, 2018).
It needs to be emphasized that the phosphorylation of MLC
is connected to the formation of fibrous actin (via activation
of actin nucleation proteins – e.g., gelsolin, profilin, cofilin,
as mentioned) and vice versa. It was suggested that actin
polymerization is necessary for force development (Mehta
and Gunst, 1999). Therefore, the actin relaxation/contraction
state is to some extent connected with the (de)polymerization
of actin. The effects of certain drugs on fenestrations may
be a sum of both.
Regulation via NO
Nitric oxide is one of the most important signaling molecules
in endothelial cells and plays a crucial role in the maintenance
of fenestrations in LSEC (DeLeve, 2015). NO stimulates sGC
synthase and thus increases the cGMP level which then
starts a cascade of signaling. cGMP stimulates the efflux of
intracellular calcium into endoplasmic reticulum storage which
reduces activation of MLCK through calmodulin. There are
also suggestions that cGMP in microvascular endothelium
can act through PKG to activate MLCP leading to further
dephosphorylation of MLC (Rigor et al., 2013), but this
mechanism was shown only in vascular smooth muscle cells.
As described above, we propose that inactivation of MLCK
together with a decrease in Ca2+ leads to actin relaxation, which
results in the increase in fenestration diameter and/or number.
There is also evidence of crosstalk between cGMP and cAMP
levels which could further affect the MLC phosphorylation state
(Chong et al., 2005). The exact mechanisms of action of NO
on LSEC fenestration have not been described yet, however
the cGMP/Ca pathway has been shown to be a part of VEGF
induced NO production (Xie et al., 2012b; DeLeve, 2015). Two
main sources of intracellular NO are synthases eNOS (activated
among others by VEGF, endothelin, or estrogen) and iNOS
(activated by cytokines during liver injuries). Both are responsible
for LSEC phenotype maintenance as well as cell response to
pathophysiological conditions (DeLeve et al., 2003b). The results
of treatment with PMA — which activates PKC and can lead
to increased NO production by eNOS — show a positive
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TABLE 4 | Agents with known mechanism of action and their effects on LSEC
fenestrations.
Inhibitor Target Effect References
C3 transferase RhoA FN ↑, D ↑ Yokomori et al., 2004
Simvastatin CD47 FN ↑, D ↑ Hunt et al., 2019
Y27635 ROCK FN ↑ Venkatraman and
Tucker-Kellogg, 2013
W7 Calmodulin D ↑ Oda et al., 1993
7 keto cholesterol Lipid rafts FN ↑, D ↑ Svistounov et al., 2012
Amlodipine Ca channel FN ↑ Hunt et al., 2019
Promotor/activator Target Effect References




cGMP FN↑ Hunt et al., 2019
Phorbol myristate PKC FN↓ de Zanger et al., 1997
Thrombospondin CD47 Defenestration Venkatraman and
Tucker-Kellogg, 2013
Simvastatin NO FN ↑, D ↓ Venkatraman and
Tucker-Kellogg, 2013; Hunt
et al., 2019
Serotonin Ca channel D↓ Gatmaitan and Arias, 1993;
Braet et al., 1995a
FN, fenestration number; D, fenestration diameter; ↑/↓, increase/decrease.
effect on maintenance of LSEC morphology in vitro (de Zanger
et al., 1997). The effect was confirmed by co-administration of
staurosporine, which inhibits PKC.
The effect of NO is complex and involves many different
pathways. Besides cGMP signaling, NO can (competitively to
O2) bind to complex IV in mitochondria, blocking the electron
transport chain which results in an increased ROS production
(Moncada and Erusalimsky, 2002). NO can then combine
with ROS creating highly reactive peroxynitrate ONOO−. NO
production by NOS is calcium dependent but at the same
time NO contributes to changes in intracellular calcium. Those
mechanisms seem to work as a feedback loop gently steering
the cell response, especially since NO is not a stable molecule
so its influence is restricted to areas local to its synthesis. In
LSEC, NO is required for fenestration maintenance. However,
it is not sufficient alone, and other NO independent pathways
are necessary. It has been shown that, besides NO production
stimulated by VEGF, NO-independent VEGF signaling is needed
also (Xie et al., 2012b). We propose two possible mechanisms: in
endothelial cells VEGF can act through its membrane receptor
on PLC, followed release of the Ca2+ from the endoplasmic
reticulum (Rigor et al., 2013). Then, PKC enters a feedback
loop of NO production leading to a decrease in Ca2+. This
would even further increase the NO production, but also
would act as a balancing effect for calcium ions. NO can also
induce protein S-nitrosilation, however it has been found not to
affect fenestrations (Xie et al., 2012b). The other possibility is,
reported in HUVEC, inhibition of Rho/ROCK pathway by VEGF
receptors (Tagashira et al., 2018) which has been shown to play an
important role in fenestration maintenance.
The cGMP pathway is a promising target for novel
therapeutics for liver diseases and aging as restoration of cGMP
levels can restore fenestrations in LSEC (Xie et al., 2012b).
Drugs such as sildenafil influence cGMP by blocking its efflux
by ABC transporters and degradation by phosphodiesterases
(PDE) (Toque et al., 2008; Sager et al., 2012). Amlodipine, a
blood pressure medication also affects fenestrations by acting
through both cGMP and inhibition of Ca2+ channels (Berkels
et al., 2004). Another drug used for lowering blood lipid
levels – simvastatin, promotes NO production directly via
the Akt pathway and through inhibition of Rho GTPases
(de Sotomayor and Andriantsitohaina, 2001).
Regulation via ROS
There are many sources of ROS within the cell, such as the
mitochondrial electron transport chain, NADPH and xanthine
oxidase and, highly expressed in endothelium, eNOS when
uncoupled (Widlansky and Gutterman, 2011; Jerkic and Letarte,
2015). ROS were initially considered mostly as cytotoxic,
but recent reports summarize their positive regulatory roles
both in physiological and pathological endothelium, reviewed
in Widlansky and Gutterman (2011).
Recently the cytoprotective role of ROS through activation
of autophagy signaling was shown in early ischemia injury
(Bhogal et al., 2018). LSEC morphology is sensitive to ROS
levels and many agents act through this mechanism, such as
e.g., ethanol and acetaminophen causing the disappearance of
fenestrations (Deaciuc et al., 1999). In vivo studies showed large
gaps in LSEC caused by ROS, generated by xanthine oxidase and
hypoxanthine suggesting destabilization of fenestrations which
also prevent cells from closing those gaps (Deaciuc et al., 1999).
Glutathione (GSH) is the main physiological countermeasure to
free radicals such as ROS. Reducing agents such as NAC can
reduce the depletion of GSH due to the presence of oxidative
stress (Sun et al., 2014). The effect of ROS on fenestrations
may come from different mechanisms based on the disturbance
of the redox balance in the cell. Intracellularly, mitochondria
are the main source of ROS while glycolysis is the main
source of reducing agents such as GSH and NADH. Scavenging
of ROS directly activates the Rho/ROCK signaling pathways
(Popova et al., 2010) which may lead to promotion of stress
fibers. By analogy, the reduction of ROS by antioxidants should
lead to reduction of Rho/ROCK signaling, therefore promoting
fenestration formation. This mechanism would explain the age-
related defenestration associated with higher levels of ROS and
reduced redox capabilities in the cells (Herrera et al., 2010).
In endothelial cells, ROS can act as a messenger molecule
activating various signaling pathways. Besides the mitochondria,
a second main ROS source are NAD(P)H oxidases which can
be stimulated by various vasoactive agents (Griendling et al.,
2000). It has been shown that LSEC morphology is sensitive
to both vasodilators and vasoconstrictors, which was shown
to increase and decrease the fenestration diameter respectively
(Table 2). Moreover, LSEC lack underlying smooth muscles
cells to emphasize the response to vasoconstrictors/dilators.
There might exist more complicated cellular mechanisms in
LSEC to compensate for this. Altogether, those findings suggest
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that ROS may be part of signaling cascades activating redox-
sensitive proteins.
CONCLUSION
Drug clearance mediated by the liver is heavily dependent
on the proper phenotype of LSEC, including the transport
through fenestrations. Individual drugs and stimulants have
been reported to influence the porosity of LSEC. Some drugs
show beneficial effects on LSEC phenotype, potentially allowing
re-opening fenestration (“re-fenestration”) which could be of
benefit in the elderly. The role of LSEC senescence and “anti-
aging” senolytic drugs, with regard to porosity, warrants further
study. However, the background of polypharmacy (regular
daily consumption of 4 or more medicines) in much of the
elderly population needs to be considered in the refenestration
context. Within this review we highlighted the areas of research
which will be particularly beneficial for both physicians and
researchers. LSEC research is growing in recent years and
the latest stage of our knowledge about fenestrations is now
facilitated with novel microscopic techniques. These super-
resolution methods will continue to improve, so it is appropriate
for the field to simultaneously improve sample status, for
example to examine living LSEC, or “wet” fixed preparations
of LSEC or whole liver mounts instead of dehydrated cells.
The substrate upon which LSEC are typically cultured also
likely needs to be re-worked – tissue culture plastic is
considerably stiffer than the LSEC’s natural surroundings, so
other softer gel-based substrates should be considered, such
as those described by Guixé-Muntet et al. (2020). Ultimately,
in vivo imaging of LSEC fenestrations in situ would be
the ideal real-time test of refenestration therapies, but the
challenges (e.g., movement due breathing and heart beat) for
this type of technology are rather significant. That said, existing
technologies should allow for comprehensive studies and better
understanding of these unique structures, and how they work, in
the coming years.
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